Trials / Recruiting
RecruitingNCT06755827
Pilot Testing a Novel Approach to Pediatric Obesity Treatment
Emotion Regulation Intervention to Improve Neural Responsiveness and Health
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Texas Tech University · Academic / Other
- Sex
- All
- Age
- 11 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to learn if an emotion regulation and self-monitoring intervention can help treat overweight and obesity in teens. The main question it aims to answer is: * Does emotion regulation and self-monitoring help reduce biases in teens with overweight and obesity? * Do changes in biases relate to changes in health functioning and health behavior? Researchers will compare the intervention to the provision of educational handouts about overweight and obesity to see if the intervention is more effective. Participants will: * Complete self-report questionnaires, an fMRI scan, and have their blood drawn * Received educational handouts or attend weekly telehealth group sessions weekly for four weeks and be asked to self-monitor their mood and behavior between sessions * Return to complete the same questionnaires, fMRI and blood draw procedures
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Emotion regulation and self-monitoring to treat pediatric obesity | Participants will attend telehealth group sessions once weekly and be asked to self-monitor their mood and health behaviors daily between sessions. |
| OTHER | Psychoeducation | Participants who are randomized to the control group will receive an online, one-time, self-led psychoeducation program with information about current daily sleep, diet, and physical activity recommendations (e.g., information about sleep hygiene, the food pyramid, and recommendations for 60 minutes of moderate-to-vigorous physical activity daily). |
Timeline
- Start date
- 2026-02-28
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-01-01
- Last updated
- 2026-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06755827. Inclusion in this directory is not an endorsement.